Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Sai Life Sciences Limited

SAILIFE.NS ✓ COMPLIANTFree checks used up today ☆ Track — members

NSE · Healthcare · Pharmaceuticals ·

India Mid Cap Analyst: STRONG BUY

Last Close

$15.35

▼ -0.61%

Market Cap $3.24B · Vol 724.74K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

86.04

FWD: 63.08

Market Cap

$3.24B

Mid Cap

Div Yield

N/A

EPS Growth

+20.63%

YoY

RSI (14)

26.24

Momentum

Beta

N/A

vs Market

52W High

$17.81

13.99% below

52W Low

$8.23

77.81% above

Volume

724.74K

Avg 771.00K

P/B

8.29

Price-to-book

ROE

15.48%

Return on equity

Free Float

63.72%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Sai Life Sciences Limited (SAILIFE.NS) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SAILIFE.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-6.15%

-7.74%

+14.95%

+47.60%

YTD

+60.98%

+68.43%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$234.60M
Net Income	$37.33M
Revenue Growth (YoY)	+11.66%
Gross Margin	60.55%
Operating Margin	21.22%
Net Profit Margin	15.91%
ROE	15.48%
ROA · ROIC	13.74% · 14.26%

P/E Ratio	86.04
Forward P/E (FY1)	63.08
PEG Ratio	0.65
P/S	9.42
P/B	8.29
P/FCF	N/A
EPS Growth	+20.63%
Outstanding Shares	212.47M

Technical Indicators

50-Day SMA	$15.84
200-Day SMA	$12.22
RSI (14)	26.24
Beta	N/A
52-Week High	$17.81
52-Week Low	$8.23

Volume Today	724.74K
Avg Daily Volume (30D)	771.00K
Relative Volume	0.94x
Volatility (10D)	28.27
Volatility (30D)	34.94
Free Float	63.72%

Analyst Consensus

STRONG BUY

Current Price $15.35

Mean Target $16.40

52W Low$8.23 52W High$17.81

Current

Target

$8.23 $17.81

Current Analyst target

+6.88% upside potential · 5 analysts

Identifiers

ExchangeNSE

FIGIBBG001T0LM76

ISININE570L01029

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 5, 2026

TypeStocks

Instrument TypeUNT Unit

Similar Halal Stocks

LLY Eli Lilly and Company -1.36% JNJ Johnson & Johnson -5.73% ABBV AbbVie Inc. -2.40% NVS Novartis AG -0.99% NOVN.S Novartis AG -0.55%

Company Profile

Sai Life Sciences Limited is an India-based company. The Company is a contract research, development, and manufacturing organization (CRDMO). It offers a range of tailor-made services for biotech firms or global pharma company requirements. Its services include integrated drug discovery services, drug metabolism and pharmacokinetics (DMPK), synthetic & medicinal chemistry, biology services, general toxicology, genotoxicity, and computational chemistry services. It also offers chemistry, manufacturing and controls (CMC) services which include route scouting, process familiarization, optimization & development, analytical method development & validation, process safety evaluation, stability studies, and early phase scale-up. Its discovery biology facility provides exploratory biology services to the expanding array of start-up and biotech companies in the Boston area and to companies in North America.